| General Information of Drug Metabolite (DM) (ID: DM005160) |
| DM Name |
Remdesivir Alanine Metabolite (Ala-Met; GS-704277)
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Adenosine 5'-monophosphoramidase (HINT1)
|
DME0215
|
| Unclear - Unclear |
Remdesivir
|
[1] |
|
Adenosine 5'-monophosphoramidase (HINT1)
|
DME0215
|
| Unclear |
Remdesivir
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Remdesivir |
DR5430
|
Approved |
Coronavirus Disease 2019 (COVID-19) |
|
|
| References |
| 1 |
Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
